EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Alpha2-Plasmin Inhibitor C-Terminal Heterogeneity on Clot Lysis and Clot Structure

Réka Bogáti iD, Barbara Baráth, Dóra Pituk iD, Rita Orbán-Kálmándi, Péter Szűcs iD, Zoltán Hegyi iD, Zsuzsanna Bereczky iD, Zsuzsa Bagoly iD, Éva Katona iD

Biomolecules · 2025

DOI: 10.3390/biom15081127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Réka Bogáti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: alpha-2-Antiplasmin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office (NKFIH), University of Debrecen Scientific Research Bridging Fund [DETKA], Hungarian Academy of Sciences, MTA-DE Lendület "Momentum" Hemostasis and Stroke Re-search Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha2-plasmin inhibitor (α2PI) has a heterogeneous structure due to proteolytic cleavages in the circulation. The C-terminally cleaved form loses the plasminogen binding site and is, therefore, a slow plasmin inhibitor (NPB-α2PI). As FXIII primarily crosslinks the plasminogen-binding intact form (PB-α2PI) to fibrin, the effect of NPB-α2PI on fibrinolysis has been less studied. Herein, we investigated the effect of C-terminal truncation. Total-, PB-, and NPB-α2PI antigen levels and α2PI incorporation were measured by ELISAs from samples of 80 healthy individuals. Clot lysis parameters of the same subjects were investigated using an in vitro clot lysis assay. α2PI incorporation into the clot was demonstrated by Western blotting. Clot lysis and clot structure were also analyzed using an α2PI-deficient plasma substituted with recombinant PB- and NPB-α2PI. Both plasma and clot-bound levels of total- and NPB-α2PI showed a significant positive correlation with clot lysis parameters. NPB-α2PI was detected in the clot due to non-covalent binding. Regardless of the type of binding, both forms affected the clot structure by increasing the thickness of the fibrin fibers and reducing the pore size. In conclusion, we found that NPB-α2PI can bind non-covalently to fibrin, and this binding contributes to changes in clot structure and inhibition of fibrinolysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-2-AntiplasminHumansMaleFemaleYoung AdultAdultMiddle AgedFibrinolysinBlood CoagulationFibrinProtein Binding

Stichwörter der Autor:innen

alpha2-plasmin inhibitorantiplasminclot lysisconfocal laser scanning microscopyfibrinolysis

Substanzen

Fibrinolysinalpha-2-AntiplasminFibrin

Autor:innen und Institutionen

  • Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Kálmán Laki Doctoral School, University of Debrecen, 4032 Debrecen, Hungary.
  • Department of Biochemistry, Semmelweis University, 1094 Budapest, Hungary.
  • Healthcare Industry Institute, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.
  • Department of Anatomy, Histology and Embryology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • MTA-DE Lendület "Momentum" Hemostasis and Stroke Research Group, 4032 Debrecen, Hungary.

ORCID-Profile: Réka Bogáti, Dóra Pituk, Péter Szűcs, Zoltán Hegyi, Zsuzsanna Bereczky, Zsuzsa Bagoly, Éva Katona

Förderung

  • National Research, Development and Innovation Office (NKFIH)
  • University of Debrecen Scientific Research Bridging Fund [DETKA]
  • Hungarian Academy of Sciences, MTA-DE Lendület "Momentum" Hemostasis and Stroke Re-search Group
  • University of Debrecen Scientific Research Bridging Fund
  • Hungarian Academy of Sciences
  • University of Debrecen

Zitieren

APA

Bogáti, R., Baráth, B., Pituk, D., Orbán-Kálmándi, R., Szűcs, P., Hegyi, Z., Bereczky, Z., Bagoly, Z., & Katona, É. (2025). Effect of Alpha2-Plasmin Inhibitor C-Terminal Heterogeneity on Clot Lysis and Clot Structure. Biomolecules. https://doi.org/10.3390/biom15081127

Vancouver

Bogáti R, Baráth B, Pituk D, Orbán-Kálmándi R, Szűcs P, Hegyi Z, et al. Effect of Alpha2-Plasmin Inhibitor C-Terminal Heterogeneity on Clot Lysis and Clot Structure. Biomolecules. 2025. doi:10.3390/biom15081127

BibTeX
@article{Bogti2025,
  author = {Bogáti, Réka and Baráth, Barbara and Pituk, Dóra and Orbán-Kálmándi, Rita and Szűcs, Péter and Hegyi, Zoltán and Bereczky, Zsuzsanna and Bagoly, Zsuzsa and Katona, Éva},
  title = {Effect of Alpha2-Plasmin Inhibitor C-Terminal Heterogeneity on Clot Lysis and Clot Structure},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15081127}
}
Kostenlos starten →